How long should you take Pazopanib (Victor) and do you need to periodically stop taking it?

Pazopanib is a multi-target tyrosine kinase inhibitor mainly used to treat advanced renal cell carcinoma and soft tissue sarcoma. Patients are often concerned about whether they need to discontinue medication periodically during long-term use. Generally speaking, pazopanib is a continuous oral drug, and its standard usage is a daily fixed dose for long-term use, rather than periodic administration like chemotherapy. However, in clinical practice, based on the patient's tolerance and adverse reaction performance, doctors may recommend periodic discontinuation of medication or dose adjustment to ensure efficacy while minimizing toxic and side effects.

During the use of pazopanib, common adverse reactions include hypertension, abnormal liver function, diarrhea, fatigue, nausea, etc. If the patient experiences severe liver function damage (such as elevated transaminases), uncontrollable high blood pressure, or other obvious adverse reactions during treatment, the doctor may ask to suspend the medication and resume taking it after the condition is relieved. This kind of discontinuation is not a fixed "cyclical discontinuation", but a temporary adjustment based on individualized responses. Therefore, patients should not discontinue medication on their own, but should strictly follow the doctor's monitoring results.

After some patients take pazopanib for a period of time, if their tumor burden decreases significantly and their condition is stable, doctors may consider appropriately extending the follow-up interval or briefly discontinuing the drug for observation. This kind of situation is not common in actual clinical practice, but for patients whose disease is well controlled and who develop tolerance problems after long-term medication, discontinuation of medication for observation or low-dose maintenance therapy is also one of the possible strategies. However, such adjustments need to be based on detailed imaging examinations and hematological indicators and cannot be decided on their own.

In general, the principle of use of pazopanib is to continue taking it for a long time, and if necessary, discontinue the drug for a short period of time as a strategy to deal with adverse reactions. During the treatment period, patients should undergo regular liver function, blood pressure and blood routine tests, and communicate with the attending doctor in a timely manner. If you need to stop medication or adjust the dosage, you should follow your doctor's instructions and do not perform "cyclical medication discontinuation" on your own. In this way, we can not only ensure the efficacy of the drug, but also reduce the risk of toxic side effects and achieve longer-term treatment benefits.

Reference link:https://www.drugs.com